
183133-96-2 Cabazitaxel
CAS:183133-96-2
MF:C45H57NO14
MW:835.93
EINECS:680-632-7
MDL No.:MFCD18827611
Properties
Appearance White to Off-White White solid.
Melting point:180 °C
Boiling point:870.7±65.0 °C
Density 1.31
storage temp. Inert atmosphere,Store in freezer, under -20°C
solubility Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
pka11.20±0.46
Application:
Cabazitaxel is a microtubule inhibitor that is suitable for use in combination with Prednisone or Prednisolone to treat hormone refractory metastatic prostate cancer patients who have previously been treated with Docetaxel containing regimens. It achieves more precise treatment throughout the entire treatment process. It works by disrupting the microtubule network that is crucial for mitosis and interphase cell function, causing inhibition of cell division and cell death. It has been shown that Jevtana inhibits cell division and tumor cell proliferation by binding and stabilizing microtubule proteins, which are proteins in the microtubules of cells that provide the skeleton to maintain cell shape.
Synonyms:
CABAZITAXEL
183133-96-2
Cabazitaxelum
XRP-6258
Jevtana Kit
Cabazitaxel Injection
Jevanta
Jevtana
Benzenepropanoic acid, beta-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (alphaR,betaS)-
Cabazitaxel
(((tertbutoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoate1-hydroxy-7beta,10beta-dimethoxy-9-oxo-5beta,20-epoxytax-11-ene-2alpha,4,13alpha-triyl 4-acetate 2-benzoate 13-((2R,3S)-3-
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate.
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-ene-2,4,13-triyl 4-acetate 2-benzoate 13-((2R,3S)-3-(((tertbutoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoate)
Hot Tags: 183133-96-2 cabazitaxel, China 183133-96-2 cabazitaxel manufacturers, suppliers, 4S 5R 4 Methyl 5 phenyloxazolidin 2 one, Cyclopropylacetic acid, Cobalt carbonyl, Cefprozil hydrate, Mpeg cl 1 50hr, 2 Phenylbutyric acid

